Statistical Methods in Medical Research

Article	Citations
Exact interval estimation for the linear combination of binomial proportions	145
A Bayesian beta-binomial piecewise growth mixture model for longitudinal overdispersed binomial data	83
Omnibus test for restricted mean survival time based on influence function	73
Interval estimation in three-class receiver operating characteristic analysis: A fairly general approach based on the empirical likelihood	63
Covariate adjustment in Bayesian adaptive randomized controlled trials	35
Confidence estimation based on data from independent studies	34
Time-varying coefficient additive hazards model with latent variables	30
Equivalence tests for ratio of means in bioequivalence studies under crossover design	29
Analysis of hospital readmissions with competing risks	28
Semiparametric copula method for semi-competing risks data subject to interval censoring and left truncation: Application to disability in elderly	28
Joint meta-analysis of two diagnostic tests accounting for within and between studies dependence	25
A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over time	23
A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families	22
Commentary on the use of the reproduction number R during the COVID-19 pandemic	22
Generalized Bayesian kernel machine regression	21
Generalised pairwise comparisons for trend: An extension to the win ratio and win odds for dose-response and prognostic variable analysis with arbitrary statements of outcome preference	20
Modeling and estimating a threshold effect: An application to improving cardiac surgery practices	19
Between-group comparison of area under the curve in clinical trials with censored follow-up: Application to HIV therapeutic vaccines	19
Accounting for informative observation process in transition models of binary longitudinal outcome: Application to medical record data	19
Response-adaptive treatment randomization for multiple comparisons of treatments with recurrent event responses	18
Multiplicative versus additive modelling of causal effects using instrumental variables for survival outcomes – a comparison	17
Developing clinical prediction models when adhering to minimum sample size recommendations: The importance of quantifying bootstrap variability in tuning parameters and predictive performance	17
Correlational analyses of biomarkers that are harmonized through a bridging study due to measurement errors	16
New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression models	16
Nonparametric analysis of doubly truncated and interval-censored data	16

Analyzing heterogeneity in biomarker discriminative performance through partial time-dependent receiver operating characteristic curve modeling	16
Revisiting performance metrics for prediction with rare outcomes	14
A family of Bayesian prognostic and predictive covariate-adjusted response-adaptive randomization designs	13
On flexible inverse probability of treatment and intensity weighting: Informative censoring, variable selection, and weight trimming	13
Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint	13
A capture-recapture modeling framework emphasizing expert opinion in disease surveillance	12
Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials	12
Random survival forests with multivariate longitudinal endogenous covariates	12
Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network	12
Inference for the treatment effect in longitudinal cluster randomized trials when treatment effect heterogeneity is ignored	11
Quantifying proportion of treatment effect by surrogate endpoint under heterogeneity	11
A unified approach based on multidimensional scaling for calibration estimation in survey sampling with qualitative auxiliary information	11
Inference on the overlap coefficient: The binormal approach and alternatives	11
Familywise error rate control for block response-adaptive randomization	11
Augmenting contact matrices with time-use data for fine-grained intervention modelling of disease dynamics: A modelling analysis	11
Bayesian order constrained adaptive design for phase II clinical trials evaluating subgroup-specific treatment effect	11
Fitting joint models of longitudinal observations and time to event by sequential Bayesian updating	11
A Bayesian genomic selection approach incorporating prior feature ordering and population structures with application to coronary artery disease	10
A simple and robust parametric shared frailty model for recurrent events with the competing risk of death: An application to the Carvedilol Prospective Randomized Cumulative Survival trial	10
Allowing for stratification in sample size planning of two-arm trials with continuous or binary outcome: Overview and tutorial	10
Evaluating prognostic biomarkers for survival outcomes subject to informative censoring	10
Smoothing Lexis diagrams using kernel functions: A contemporary approach	10
Covariate selection for optimizing balance with an innovative adaptive randomization approach	9
Quantification of the influence of risk factors with application to cardiovascular diseases in subjects with type 1 diabetes	9
An iterative matrix uncertainty selector for high-dimensional generalized linear models with measurement errors	9
Estimating a time-to-event distribution from right-truncated data in an epidemic: A review of methods	9
General regression methods for respondent-driven sampling data	9
Modeling the patient mix for risk-adjusted CUSUM charts	9
Adjusting for switches to multiple treatments: Should switches be handled separately or combined?	8
Penalized variable selection in multi-parameter regression survival modeling	8
A generalization of moderated statistics to data adaptive semiparametric estimation in high-dimensional biology	8
Modified Brier score for evaluating prediction accuracy for binary outcomes	8
The effect of estimating prevalences on the population-wise error rate	8
Causal simulation experiments: Lessons from bias amplification	8
Review of sample size determination methods for the intraclass correlation coefficient in the one-way analysis of variance model	8
More efficient estimators of the area under the receiver operating characteristic curve in paired ranked set sampling	8
Model-based adaptive randomization procedures for heteroscedasticity of treatment responses	8
Sample size calculation for multi-arm parallel design with restricted mean survival time	8
Complete effect decomposition for an arbitrary number of multiple ordered mediators with time-varying confounders: A method for generalized causal multi-mediation analysis	7
Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials	7
Testing for marginal covariate effect when the subgroup size induced by the covariate is informative	7
MISL: Multiple imputation by super learning	7
Test sensitivity in a prospective cancer screening program: A critique of a common proxy measure	7
A competing risks regression model for the association between time-varying opioid exposure and risk of overdose	7
Change plane model averaging for subgroup identification	7
Cause-specific hazard Cox models with partly interval censoring – Penalized likelihood estimation using Gaussian quadrature	7
A tight fit of the SIR dynamic epidemic model to daily cases of COVID-19 reported during the 2021–2022 Omicron surge in New York City: A novel approach	7
The analysis of COVID-19 in-hospital mortality: A competing risk approach or a cure model?	7
On recurrent-event win ratio	7
A semiparametric mixture model approach for regression analysis of partly interval-censored data with a cured subgroup	7

Regression analysis of multivariate recurrent event data allowing time-varying dependence with application to stroke registry data	7
Hunting for protective drugs at the break of a pandemic: Causal inference from hospital data	7
Space-time interactions in Bayesian disease mapping with recent tools: Making things easier for practitioners	7
Estimation and inference on the partial volume under the receiver operating characteristic surface	7
Improved and computationally stable estimation of relative risk regression with one binary exposure	6
Combining multiple biomarkers linearly to minimize the Euclidean distance of the closest point on the receiver operating characteristic surface to the perfection corner in trichotomous settings	6
A Weibull mixture cure frailty model for high-dimensional covariates	6
Mid-quantile regression for discrete responses	6
Fixed and random effect selections in generalized linear mixed models	6
Local linear approximation with Laplacian smoothing penalty and application in biology	6
Estimand-based inference in the presence of long-term survivors	6
Time-dependent receiver operating characteristic curve estimator for correlated right-censored time-to-event data	6
Use of clinical tolerance limits for assessing agreement	6
Interval estimation for the Youden index of a continuous diagnostic test with verification biased data	6
qTPI: A quasi-toxicity probability interval design for phase I trials with multiple-grade toxicities	6
Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviour	6
Flexible extension of the accelerated failure time model to account for nonlinear and time-dependent effects of covariates on the hazard	6
Using short-term endpoints to improve interim decision making and trial duration in two-stage phase II trials with nested binary endpoints	6
Statistical methods for clinical trials interrupted by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic: A review	6
Estimation in discrete time coarsened multivariate longitudinal models	6
A Bayesian latent class approach to causal inference with longitudinal data	6
Multiple imputation approaches for epoch-level accelerometer data in trials	6
CFO: Calibration-free odds design for phase I/II clinical trials	6
A new framework for semi-Markovian parametric multi-state models with interval censoring	6
BOIN-ETC: A Bayesian optimal interval design considering efficacy and toxicity to identify the optimal dose combinations	6
Heterogeneous treatment effect estimation for observational data using model-based forests	5
Editorial	5
Adaptive enrichment trial designs using joint modelling of longitudinal and time-to-event data	5
Comparison of statistical methods for the analysis of patient-reported outcomes in randomised controlled trials: A simulation study	5
Distribution-free control charts for mixed-type data based on rank of interpoint distances	5
Divided-and-combined omnibus test for genetic association analysis with high-dimensional data	5
Simulation extrapolation method for measurement error: A review	5
A new measure to quantify sedentary behavior using accelerometer data: Application to the Hispanic Community Health Study/Study of Latinos	5
LASSO-type instrumental variable selection methods with an application to Mendelian randomization	5
Bayesian analysis of joint quantile regression for multi-response longitudinal data with application to primary biliary cirrhosis sequential cohort study	5
Unbiased and robust analysis of co-localization in super-resolution images	5
The “Why” behind including “Y” in your imputation model	5
A generalized epidemiological model with dynamic and asymptomatic population	5
Solutions to problems of nonexistence of parameter estimates and sparse data bias in Poisson regression	5
Quantile outcome adaptive lasso: Covariate selection for inverse probability weighting estimator of quantile treatment effects	5
Regularization approaches in clinical biostatistics: A review of methods and their applications	5
Additive hazards model with time-varying coefficients and imaging predictors	5
MEGH: A parametric class of general hazard models for clustered survival data	5
Unified approach to optimal estimation of mean and standard deviation from sample summaries	5
Variance partitioning in spatio-temporal disease mapping models	5
Sample sizes required to estimate the protective efficacy of a vaccine when there is an unequal allocation of individuals across the vaccine and placebo groups	5
Generalized fiducial inference for the restricted mean survival time	5
Group lasso priors for Bayesian accelerated failure time models with left-truncated and interval-censored data	5
Estimating the sample mean and standard deviation from order statistics and sample size in meta-analysis	5
Bayesian variable selection in hierarchical difference-in-differences models	5
An overview of optimal designs under a given budget in cluster randomized trials with a binary outcome	5
An objective Bayesian approach to estimation in multistage experiments	5
Data-driven clustering of infectious disease incidence into age groups	5
Average treatment effect on the treated, under lack of positivity	5
Bivariate copula regression models for semi-competing risks	5
Semiparametric generalized estimating equations for repeated measurements in cross-over designs	5
Sample size determination for adaptive crossover trial in detecting gene-drug interactions	4
Causal rule ensemble method for estimating heterogeneous treatment effect with consideration of prognostic effects	4
Comparisons of various estimates of the I2 statistic for quantifying between-study heterogeneity in meta-analysis	4
Extended excess hazard models for spatially dependent survival data	4
Biomarker-driven optimal designs for patient enrollment restriction	4
A distribution-free smoothed combination method to improve discrimination accuracy in multi-category classification	4
Covariate-adjusted inference for doubly adaptive biased coin design	4
Graphical methods to illustrate the nature of the relation between a continuous variable and the outcome when using restricted cubic splines with a Cox proportional hazards model	4
Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in multiple sclerosis	4
Clustering functional data using forward search based on functional spatial ranks with medical applications	4
Fallopian tube anatomy predicts pregnancy and pregnancy outcomes after tubal reversal surgery	4
Factorial survival analysis for treatment effects under dependent censoring	4
Variable selection with missing data in both covariates and outcomes: Imputation and machine learning	4
Youden index estimation based on group-tested data	4
Measuring the individualization potential of treatment individualization rules: Application to rules built with a new parametric interaction model for parallel-group clinical trials	4
Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints	4
Isotonic design for single-arm biomarker stratified trials	4
Simulating time-to-event data subject to competing risks and clustering: A review and synthesis	4
Bivariate joint models for survival and change of cognitive function	4
The change in estimate method for selecting confounders: A simulation study	4
Efficient algorithms for survival data with multiple outcomes using the frailty model	4
Jointly assessing multiple endpoints in pilot and feasibility studies	4
Efficient estimation of the marginal mean of recurrent events in randomized controlled trials	4
Model detection for semiparametric accelerated failure additive model with right-censored data	4

A comparison of various aggregation functions in multi-criteria decision analysis for drug benefit–risk assessment

4